Previous efforts to eradicate malaria failed for several reasons, including political instability and technical challenges in delivering resources, especially in certain countries in Africa.

There has been treatment for hepatitis C, but the treatment has not been overwhelmingly effective, number 1. And number 2, it has had considerable toxicity.

What has happened over the years is that scientists have now developed AIDS therapeutic capabilities, as well as prevention, and we've linked prevention and treatment in a way that if you fast-forward 30 years form '88 to now, we can say without hyperbole that we have the tools, if implemented the way they could be implemented, to theoretically, essentially end the epidemic as we know it now.

The nature of a protective immune response to HIV is still unclear. Because in a very, very unique manner, unlike virtually any other microbe with which we're familiar, the HIV virus has evolved in a way that the immune system finds it very difficult, if not impossible, to deal with the virus.

The Europeans have lots of data on the use of adjuvanted flu vaccine in the elderly, but I dont think anybody has really good data on adjuvants in children.

Certainly the support for research in HIV/AIDS was good in the Clinton administration, good in the Bush administrations. It just was.

Exposures, if they are mild, in the sense of barely just a small concentration, it's mostly an irritant, particularly the peroxides, that in that smoke would irritate the skin or even irritate the lungs. So, for the most time, it could be either just a little bit of a nuisance irritant, or if you get a really big whiff of it, particularly people who have, for example, reversible airways disease, like asthma or different types of hypersensitivity diseases, you could get a serious problem.